SCHEMBL29648307

SCHEMBL29648307

CCNS(=O)(=O)c1ccc(NCc2ccc(C(F)(F)F)cc2)c(Br)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.47
ALOX15 P16050 2/20 0.46
ALDH1A1 P00352 1/20 0.44
PTGS2 P35354 1/20 0.43
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
MMP1 P03956 1/20 0.41
SCN3A Q9NY46 1/20 0.41
PKM P14618 1/20 0.40
GHSR Q92847 1/20 0.40
PNMT P11086 1/20 0.40
CA12 O43570 1/20 0.40
CA7 P43166 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24496068 1.00 CYP19A1 (0.47) CYP19A1ALOX15ALDH1A1PTGS2CA1
SCHEMBL25801783 0.89 TEAD1 (0.46) CYP19A1ALDH1A1PTGS2CA1CA2
SCHEMBL29648341 0.88 CYP19A1 (0.47) CYP19A1PTGS2CA1CA2MAPT
SCHEMBL24496161 0.88 CYP19A1 (0.47) CYP19A1PTGS2CA1CA2MAPT
SCHEMBL29648404 0.86 CYP19A1 (0.45) CYP19A1ALDH1A1PTGS2CA1CA2
SCHEMBL24496309 0.86 CYP19A1 (0.45) CYP19A1ALDH1A1PTGS2CA1CA2
SCHEMBL29648340 0.86 PTGS2 (0.43) CYP19A1ALOX15PTGS2CA1CA2
SCHEMBL24496010 0.86 ALDH1A1 (0.51) CYP19A1ALDH1A1CA1CA2MAPT
SCHEMBL24496152 0.84 CNR2 (0.47) CYP19A1CA1CA2MEN1KMT2A
SCHEMBL24496051 0.84 MMP1 (0.49) CYP19A1ALDH1A1CA1CA2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022120353-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 WO disclosed
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 WO disclosed